First Choice Neurology

New Alzheimer’s Drug

Research Study Shows New Alzheimer’s Drug Slows Cognitive Decline

A late-stage clinical trial was conducted by Biogen and Eisai and the new Alzheimer’s drug they are developing for Alzheimer’s disease slowed the rate of cognitive decline. New Alzheimer’s Drug – Lecanemab The results were strong, and this could offer hope for a new Alzheimer’s drug. The results were strong for the new medication, lecanemab. …

Research Study Shows New Alzheimer’s Drug Slows Cognitive Decline Read More »

Biogen Seeks FDA Approval for New Alzheimer’s Drug

Biogen is planning to file for U.S. regulatory approval for its Alzheimer’s treatment aducanumab after data from more patients in two discontinued studies showed that the drug improved cognition at high doses. Patients who received aducanumab experienced significant benefits on measures of cognition and function such as memory, orientation, and language, Biogen said. In March, …

Biogen Seeks FDA Approval for New Alzheimer’s Drug Read More »

Translate »